CGNU PLC
16 August 2000
CGNU plc ('CGNU') has reached agreement, subject to contract and to
Lloyd's approval, with the Blenheim Partnership ('Blenheim')to acquire
Blenheim's 49% shareholding in Marlborough Underwriting Agency Limited
('Marlborough'), the Lloyd's managing agent. As a consequence of this
transaction, Marlborough will become a wholly-owned subsidiary of CGNU.
The consideration for this transaction is not material in relation to
CGNU's net assets.
Angus Sladen and Jill Loveless, respectively managing director and finance
director of Marlborough, have decided to resign their appointments in order
to pursue interests elsewhere and will leave Marlborough shortly after
the completion of the transaction. It is also the intention of Sir Patrick
Sheehy, non-executive chairman to resign. Clive Watson, currently the CGNU
London Markets Director will be appointed as managing director of Marlborough,
subject to Lloyd's consent.
CGNU currently provides in aggregate approximately 85% of the capacity of
Lloyd's syndicates 62, 1047 and 1861 managed by Marlborough. CGNU will
continue to support these syndicates for the 2001 year of account.
Enquiries:
Clive Watson, London Markets Director +44 (0)20 7662 2163
Analysts/Investors
Steve Riley, Investor Relations Director +44 (0)20 7662 8115
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.